A detailed history of Parallel Advisors, LLC transactions in Morphic Holding, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 4 shares of MORF stock, worth $227. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Previous 4 -0.0%
Holding current value
$227
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$19.95 - $31.0 $79 - $124
4 New
4 $0
Q4 2022

Feb 03, 2023

BUY
$24.14 - $30.37 $0 - $0
0 New
0 $0
Q4 2021

Jan 20, 2022

SELL
$43.27 - $65.72 $3,288 - $4,994
-76 Closed
0 $0
Q3 2021

Nov 02, 2021

BUY
$53.61 - $67.5 $4,074 - $5,130
76 New
76 $4,000

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.